Globela Pharma Private Limited, a active private limited company, was established on 08 February 2006 in Surat, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2006PTC047699. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹58.00 Cr and a paid-up capital of ₹56.92 Cr.
It upholds a compliant status. Employing 150 professional, Its leadership includes Mayur Anand Sirdesai (Director), Pietro Ermanno Stefanutti (Director), Bhanubhai Shambhubhai Vaghashia (Managing Director). Past directors included Krishna Tejashkumar Naik, Pragjibhai Gobarbhai Kakadia, Ravishanker Kovi. It holds ₹168.62 Cr open charges and ₹16.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 357 - 358, Road No. 3 Gidc, Sachin, Surat, Gujarat, 394230.
U24230GJ2006PTC047699
047699
08 February 2006
₹58.00 Cr
₹56.92 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Globela Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mayur Anand Sirdesai | Director | 23 Sep 2021 | Current |
| Pietro Ermanno Stefanutti | Director | 13 Jan 2022 | Current |
| Bhanubhai Shambhubhai Vaghashia | Managing Director | 08 Feb 2006 | Current |
| Priyank Vaghashia | Director | 23 Sep 2021 | Current |
| Urmilaben Bhanubhai Vaghasiya | Director | 25 Oct 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 25 Oct 2010 | Past |
| Pramod Abcsdd | Additional Director | 10 Dec 2011 | Past |
| Pramod Abcsdd | Additional Director | 23 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 23 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Globela Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.16% increase. The company also saw a substantial fall in profitability, with a 24.9% decrease in profit. The company's net worth moved up by a moderate rise of 7.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Globela Pharma had a promoter holding of 74.21% and a public holding of 25.79%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,686,200,000.00
₹159,993,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 2024 | Sidbi | ₹7.35 Cr | Open |
| 06 May 2022 | Axis Bank Limited | ₹22.06 Cr | Open |
| 25 Mar 2022 | Axis Bank Limited | ₹54.47 Cr | Open |
| 28 Mar 2017 | Axis Bank Limited | ₹42.37 Cr | Open |
| 29 Nov 2016 | Axis Bank Limited | ₹42.37 Cr | Open |
Explore comprehensive loan charge details -
Globela Pharma has a workforce of 150 employees as of Sep 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Globela Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globela Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Globela Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Sidbi amounted to Rs. 7.35 Cr with Charge ID 100967171 was registered on 05 Aug 2024. was documented.
Progress on Globela Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
The activity A charge with Axis Bank Limited of Rs. 22.06 Cr registered on 06 May 2022 with Charge ID 100568822 was modified on 05 Mar 2024. was completed.
Progress on A charge with Axis Bank Limited of Rs. 54.47 Cr registered on 25 Mar 2022 with Charge ID 100554236 was modified on 09 Jan 2024. was documented.
A charge with Axis Bank Limited of Rs. 42.37 Cr registered on 29 Nov 2016 with Charge ID 100065045 was modified on 19 Dec 2023. was recorded as a recent event.
The CIN of Globela Pharma Private Limited is U24230GJ2006PTC047699.
Globela Pharma Private Limited is headquartered at Plot No. 357 - 358, Road No. 3 Gidc, Sachin, Surat, Gujarat, 394230.
Globela Pharma Private Limited was incorporated on 08 February 2006.
The current directors of Globela Pharma Private Limited are
The primary industry of Globela Pharma Private Limited is Manufacturing.
Globela Pharma Private Limited is unlisted.
The authorized capital of Globela Pharma Private Limited is ₹58.00 Cr, and the paid-up capital is ₹56.92 Cr.
The compliance status of Globela Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX